Results 211 to 220 of about 616,611 (358)

Strong Correlation between Liver and Serum Levels of Hepatitis C Virus Core Antigen and RNA in Chronically Infected Patients [PDF]

, 2011
Vincent Descamps, Anne Op De Beeck, C. Plassart, Étienne Brochot, Catherine François, François Helle, Michael Adler, Nadine Bourgeois, Delphine Degré, Gilles Duverlie, Sandrine Castelain   +10 more
openalex   +1 more source

Maternal Gestational Low‐Grade Inflammation and the Risk of Anorexia Nervosa in Daughters

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Prenatal exposures have been suggested to have a programming effect on neural and metabolic development, which may affect the risk of eating disorders. We investigated the association between prospectively measured maternal gestational high‐sensitivity C‐reactive protein (hs‐CRP), an established inflammatory biomarker, and subsequent
Emma Saure, Pyry N. Sipilä, Cynthia M. Bulik, Elina Santti, Heljä‐Marja Surcel, Antti Latvala, Anu Raevuori   +6 more
wiley   +1 more source

Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update. [PDF]

J Viral Hepat
Lampertico P, Anolli MP, Steppich K, Wedemeyer H.   +3 more
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Chronic hepatitis B: Is it time for expanded antiviral treatment? [PDF]

World J Virol
Manrai M, Jha AA, Pachisia AV, Dawra S.
europepmc   +1 more source

PP-006 Adefovir resistance detection in chronic hepatitis B patients with primary non-response to adefovir treatment

, 2008
Shangwen Yang, Ran Xue, Q. Wang, Hao Xing, Jian‐You Guo, Wenhui Xie, Jiawei Yan, Jun Cheng   +7 more
openalex   +1 more source

ARE ELDERLY PATIENTS POOR CANDIDATES FOR PEGYLATED INTERFERON PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C? [PDF]

, 2006
Annarosa Floreani, E. Minola, I. Carderi, Francesco Ferrara, E. Rosa Rizzotto, Vincenzo Baldo   +5 more
openalex   +1 more source

The Protective Effects of Membrane‐Separated Ripe Pu‐Erh Tea Extracts Against Chronic Alcoholic Liver Injury

Food Frontiers, EarlyView.
In this study, we investigated the protective effects of different membrane‐separated ripe Pu‐erh tea on alcohol‐induced liver injury. The result indicated that ripe Pu‐erh tea separated by a 50 nm ceramic membrane (molecular weight < 300 kDa) has the best effect on preventing ALD.
Sibo Zhao, Jielin Jiang, Yan Liu, Mianhong Xu, Rui Yang, Zhi Yang, Jilin Xie, Zhanggui Ding, Liyong Luo, Liang Zeng   +9 more
wiley   +1 more source

Expression and significance of INTS10 and IRF3 in chronic hepatitis B patients. [PDF]

Front Microbiol
Ye A, Chen X, Qiu D, Wu W.
europepmc   +1 more source

Enhancing safety and efficacy of RNAi-based gene therapy for the treatment of chronic hepatitis B

, 2014
Thomas Michler, Stefan Mockenhaupt, Stefanie Große, Dirk Grimm, Ulrike Protzer   +4 more
openalex   +1 more source